Oxford Technology Management

OxCan is a startup focused on early lung cancer detection using machine learning and liquid biopsy techniques. The company has developed an artificial intelligence-based healthcare platform that identifies cancer through targeted blood testing. This platform effectively detects cancer-related materials released into the bloodstream, allowing for cost-effective and routine analysis. It evaluates multidimensional liquid biopsy results, including DNA, proteins, epigenetic factors, as well as incorporating epidemiological data and patient medical histories. By providing healthcare providers with the tools for early cancer detection, OxCan aims to facilitate timely and potentially curative treatment options.

MitoRx Therapeutics is a biotechnology company focused on developing innovative therapeutics aimed at reversing mitochondrial dysfunction. The company targets a range of conditions, including neuromuscular disorders, metabolic diseases, and dementia. By specializing in mitochondrial-protective therapies, MitoRx seeks to address the progression of challenging diseases, particularly rare indications, while also engaging in partnerships for broader applications. Their work enables healthcare professionals to potentially halt the decline associated with dystrophy and neurodegeneration.

OxCan is a startup focused on early lung cancer detection using machine learning and liquid biopsy techniques. The company has developed an artificial intelligence-based healthcare platform that identifies cancer through targeted blood testing. This platform effectively detects cancer-related materials released into the bloodstream, allowing for cost-effective and routine analysis. It evaluates multidimensional liquid biopsy results, including DNA, proteins, epigenetic factors, as well as incorporating epidemiological data and patient medical histories. By providing healthcare providers with the tools for early cancer detection, OxCan aims to facilitate timely and potentially curative treatment options.

Machine Discovery is a spin-out from the University of Oxford focused on commercializing advanced machine learning technology. The company has developed a simulation management platform that utilizes proprietary neural network technology to enhance the efficiency of compute-intensive tasks. This platform enables clients to conduct simulations with minimal data input while achieving a high level of accuracy, specifically 99.9% fidelity. By accelerating costly calculations, Machine Discovery provides valuable statistical insights that aid clients in speeding up their innovation processes, thus addressing critical demands in various sectors.

Lightpoint Medical, Ltd., a medical device company, develops imaging technologies for cancer surgery. It develops Cerenkov Luminescence Imaging technology that detects cancer in real-time during surgery, and reduces the likelihood of cancer recurrence and the need for reoperation. Lightpoint Medical, Ltd. was formerly known as Artemis Diagnostics Ltd. and changed its name to Lightpoint Medical, Ltd. in January 2013. The company was founded in 2012 and is based in Rickmansworth, United Kingdom.

Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.

Oxwash Ltd is a laundry and dry-cleaning service based in Oxford, United Kingdom, with additional locations in Cambridge and London. Founded in 2017, the company specializes in cleaning a wide range of items, including vintage and designer clothing, bedding, home textiles, and sports kits. Utilizing advanced ozone generation technology, Oxwash aims for clinically clean results while ensuring eco-friendly operations with net zero carbon emissions. The service includes collection and delivery via a fleet of electric cargo bikes, catering to both individual customers and businesses such as hotels, cafes, and educational institutions. Oxwash combines ozone disinfection with thermal and chemical processes to eliminate bacterial, fungal, and viral agents, offering a comprehensive approach to laundry that prioritizes sustainability and hygiene.

curileum discovery Ltd develops therapeutic solutions to treat gastrointestinal diseases. The company was incorporated in 2013 and is based in London, United Kingdom.

Atelerix Limited provides storage and transportation of cells and tissues at room temperature. The company provides suspended cells, planted cells, and tissues. It also discovers and tests new drugs, develops cell therapies, and stores stem cells. The company was founded in 2006 and is based in Cambridge, United Kingdom.

Lightpoint Medical, Ltd., a medical device company, develops imaging technologies for cancer surgery. It develops Cerenkov Luminescence Imaging technology that detects cancer in real-time during surgery, and reduces the likelihood of cancer recurrence and the need for reoperation. Lightpoint Medical, Ltd. was formerly known as Artemis Diagnostics Ltd. and changed its name to Lightpoint Medical, Ltd. in January 2013. The company was founded in 2012 and is based in Rickmansworth, United Kingdom.

Atelerix Limited provides storage and transportation of cells and tissues at room temperature. The company provides suspended cells, planted cells, and tissues. It also discovers and tests new drugs, develops cell therapies, and stores stem cells. The company was founded in 2006 and is based in Cambridge, United Kingdom.

Bodle Technologies Limited provides advanced optoelectronic solutions for displays and smart windows. It offers zero-power reflective displays that are bi-stable reflective displays with ultra-high resolution; smart windows; and security coatings that change color under mechanical, optical or electrical probing techniques that result in unbreakable security features in currencies, ID cards, and official documentation. Its reflective displays are used in wearables, near-eye, and projection based displays. Bodle Technologies Limited was incorporated in 2015 and is headquartered in Begbroke, United Kingdom.

Gripable is develops simple digital therapy tools, combining them with mobile games, motivating physically impaired patients. GripAble began during our research with stroke patients struggling to use their hands for simple activities. Everyday tasks - getting dressed in the morning, holding a glass of water - are a huge frustration for them. This is the reality for over 500 million people around the world suffering with impaired arm mobility. These patients need, and want, more therapy. GripAble's first product is a highly sensitive, portable hand-grip that connects wirelessly with a mobile-based app, allowing patients to play our fun therapy games. It is designed for low-cost, easy-access assessment and therapy of hand and arm disability, providing increased engagement and allowing for self-training in hospitals and at home.

Ducentis is a pre-clinical stage company aiming to develop novel therapies for inflammation and autoimmune disease. Our target is the CD200/CD200R axis which imparts a deactivating signal to activated immune cells in both the innate and adaptive arms of the immune system. Potential therapeutic targets include transplant rejection and autoimmune and inflammatory disease affecting the lung, liver, kidney, eye, bone and cartilage.

Glide Pharmaceutical Technologies Limited is a clinical-stage development company based in Abingdon, United Kingdom, specializing in solid dose formulations of therapeutics and vaccines. The company has developed the Solid Dose Injector (SDI) system, aimed at enhancing patient compliance for those self-administering long-term therapies. Its product pipeline includes solid dose formulations for medications such as octreotide, teriparatide, and vaccines for anthrax and influenza. Additionally, Glide is working on a novel non-invasive diagnostic technology focusing on prostate cancer, which seeks to identify clinically significant disease through a biochemical marker. Founded in 2001, the company was previously known as Caretek Medical Ltd. before rebranding in 2006.

OxSonics Limited develops and commercializes SonoTran, an oncological drug delivery platform and injectable sono-sensitive particles. Its SonoTran drug delivery platform delivers drugs throughout tumours, including to the areas that lie furthest from blood vessels. The company also develops a pipeline of therapies for the treatment of solid tumours, mCRC, and pancreatic ductal adenocarcinoma. OxSonics Limited was founded in 2013 and is based in Oxford, United Kingdom.

Electrowinning Technologies Ltd specializes in manufacturing power electronic equipment tailored for the metal industry, particularly focusing on copper production. Established in 2016 and based in Bristol, United Kingdom, the company offers innovative solutions such as in-suite copper concentration control for electrorefining, anodes equipped with integrated point-of-use power converters for electrowinning, and flow optimized cells for copper liberation. The technology developed by Electrowinning Technologies effectively manages the significant currents used in metal-winning operations, enhancing both the quality and quantity of produced metals while simultaneously reducing energy consumption. This technology is particularly relevant for electrorefining, which is the predominant copper refining method in Europe.

curileum discovery Ltd develops therapeutic solutions to treat gastrointestinal diseases. The company was incorporated in 2013 and is based in London, United Kingdom.

Lupe Technology Limited is a consumer technology company based in the United Kingdom that specializes in the development and manufacture of cordless vacuum cleaners. Founded in 2014, the company focuses on enhancing suction power and endurance in its products through patented suction intensifier technology, which incorporates a cyclonic system and HEPA filtration for effective cleaning. Lupe Technology's vacuum cleaners feature a motorized agitator designed to tackle various surfaces, effectively removing hair and deep-seated dirt, while a removable battery pack allows for extended cleaning without interruptions. The company aims to reinvest profits to expand its market share in the floorcare sector and explore new product verticals, solidifying its presence within the industry.

Active Needle Technology is an early-stage medical device company focused on enhancing treatment pathways through innovative image-guided interventional radiology. The company has developed a proprietary platform that utilizes ultrasonic technology to improve the accuracy of imaging and needle placement in vivo. This advancement significantly enhances the safety and efficiency of needle-based procedures, benefiting both clinicians and patients. By providing a reliable solution for medical professionals, Active Needle aims to transform how interventional radiology is performed, ultimately delivering improved healthcare outcomes.

Molecular Warehouse Ltd., incorporated in 2015 and based in Twickenham, United Kingdom, specializes in developing proteins for diagnostics and therapeutics. The company focuses on creating patient-centric biosensor technology that enhances molecular diagnostics. Their innovative electrochemical biosensors are designed to detect a variety of biomarkers with high specificity and sensitivity, allowing for rapid health monitoring. This technology enables patients to conduct regular health assessments from home and facilitates seamless communication of test results with healthcare providers through smart devices.

Ducentis is a pre-clinical stage company aiming to develop novel therapies for inflammation and autoimmune disease. Our target is the CD200/CD200R axis which imparts a deactivating signal to activated immune cells in both the innate and adaptive arms of the immune system. Potential therapeutic targets include transplant rejection and autoimmune and inflammatory disease affecting the lung, liver, kidney, eye, bone and cartilage.

Orbit Discovery Ltd. is a peptide display technology company based in Oxford, United Kingdom, founded in 2015. The company specializes in identifying peptide drugs aimed at treating chronic diseases by leveraging its innovative in vitro display technology. This technology utilizes small beads to connect randomized peptide sequences with their corresponding DNA, facilitating the screening of peptides for various disease types. Orbit Discovery focuses on developing a screening platform that identifies potential peptide drug candidates for both internal drug discovery programs and collaborative research initiatives. The company’s platform offers a means to discover and optimize novel, biologically relevant peptides, capitalizing on the unique properties of peptides that combine the specificity and efficacy of larger biologic molecules with the advantages of smaller molecules, such as reduced dosing and simpler manufacturing processes. This approach aims to enhance the discovery and development of peptide-based therapeutics.

Azellon Limited is a company based in London, United Kingdom, that specializes in the development and commercialization of a unique tissue repair technology utilizing mesenchymal stem cells combined with a biological scaffold. The company's primary product, Cell Bandage, is designed for the repair of avascular meniscal tears in the knee, addressing a significant issue in orthopedic treatment where surgeons often resort to partial or complete meniscus removal. This conventional approach can lead to osteoarthritic changes in the knee joint over time. Developed by Professor Anthony Hollander, Azellon's technology has demonstrated notable success in in-vitro models over a five-year research period. Established in 2007, Azellon Limited aims to offer a more effective solution for knee injuries that preserves the meniscus and promotes natural healing.

Lightpoint Medical, Ltd., a medical device company, develops imaging technologies for cancer surgery. It develops Cerenkov Luminescence Imaging technology that detects cancer in real-time during surgery, and reduces the likelihood of cancer recurrence and the need for reoperation. Lightpoint Medical, Ltd. was formerly known as Artemis Diagnostics Ltd. and changed its name to Lightpoint Medical, Ltd. in January 2013. The company was founded in 2012 and is based in Rickmansworth, United Kingdom.

Sime Diagnostics Ltd is a clinical AI platform company specializing in neonatal healthcare. Founded in 2014 and headquartered in London, the company develops advanced software that utilizes artificial intelligence to generate data-driven insights for medical professionals. Its primary offering is the Neonatal Lung Maturity Test (LMT), which predicts Respiratory Distress Syndrome (RDS) in premature infants, aiming to reduce morbidity and mortality rates in this vulnerable population. Sime Diagnostics leverages its patented technologies to detect diseases in real-time, facilitating early intervention for high-risk patients. Additionally, the company's AI platform curates and analyzes unique datasets that can aid in the discovery of new disease biomarkers and support third-party partners across various medical fields. With operations also in Copenhagen and Shanghai, Sime Diagnostics combines expertise in medicine and data science to address urgent healthcare needs in neonatal intensive care.

Sasets Ltd. operates Sasets.com, a cloud-based mobile asset management and logistics platform designed to enhance project management and operational efficiency. The platform offers a comprehensive range of features, including asset lifecycle management, staff rostering, health and safety automation, smart reporting, contract and site management, customer relationship management, and document control and sharing. Established in 2012 and headquartered in Henley on Thames, United Kingdom, Sasets Ltd. leverages Microsoft Azure to provide a secure and scalable service suitable for global deployment. The platform is tailored specifically for the construction industry, aiming to improve employee productivity and streamline organizational processes, with evidence suggesting that such vertical SaaS solutions can yield significant performance gains over traditional methods.

Message Missile, founded in 2013 by Thomas Young, specializes in location-based marketing solutions designed to enhance customer relationships and foster brand loyalty. The company develops mobile phone software that utilizes global positioning system (GPS) technology and geofences to deliver timely push notifications to users based on their current location. By partnering with some of the largest brands, Message Missile aims to improve engagement and create personalized marketing experiences that resonate with consumers in real-time.

Designer Carbon Materials Ltd specializes in the development of advanced nanomaterials, focusing on endohedral metallofullerenes for various applications such as energy harvesting, bio-sensing, and quantum nanoelectronics. The company emerged as a spin-out from the University of Oxford, building on over 12 years of research led by Dr. Kyriakos Porfyrakis and his team. They have successfully synthesized and chemically functionalized endohedral fullerenes, creating materials with tailored electronic properties. This innovative approach allows clients to utilize a range of nanostructures, including nanotubes and their derivatives, in both scientific and industrial applications.

Abgentis Limited develops IV/oral antibacterial products to treat acute and chronic, life-threatening and drug-resistant infections. It focuses on re-engineering Abgentis, a previously marketed antibacterial by deploying a unique insight into the structure-activity relationships, microbiology, pharmacology, and efficacy of antibacterial DNA supercoiling inhibitors. The company was incorporated in 2012 and is based in Abingdon, United Kingdom.

Run3D Limited operates clinics that specialize in musculoskeletal assessments to help individuals address persistent injuries. Founded in 2012 and based in Witney, United Kingdom, the company utilizes advanced three-dimensional gait analysis technology to evaluate biomechanics related to running injuries, performance issues, and footwear selection. Services are offered at various locations in the United Kingdom and Dublin, Ireland. Run3D employs a state-of-the-art motion capture system and draws on the world's largest biomechanical database to provide precise evaluations. The company aims to identify the root causes of injuries and develop personalized rehabilitation programs based on scientific measurements of gait, muscular strength, flexibility, and alignment. Collaborating with leading institutions such as the Running Injury Clinic at the University of Calgary, Run3D emphasizes an evidence-based approach to treating musculoskeletal overuse injuries.

Power OLEDs Ltd, based in the United Kingdom, specializes in the development and manufacturing of advanced materials for organic light-emitting diode (OLED) technology. OLEDs are recognized for their superior performance compared to traditional display technologies, offering advantages such as faster response times, wider viewing angles, and lower power consumption. Power OLEDs focuses on creating high-performance materials, including hole transporters, electron transporters, electron injectors, hosts, and emitters, which support global manufacturers in producing more efficient and durable technical devices. With a team that boasts over 60 years of combined experience in the OLED sector, the company maintains a strong intellectual property portfolio and a promising pipeline of innovative materials, positioning itself as a leader in this rapidly evolving field.

Combat Medical SL, based in Ajalvir, Spain, specializes in a novel treatment for superficial bladder cancer that enhances the efficacy of standard chemotherapy through a chemo-hyperthermia delivery system. This innovative approach involves heating chemotherapy agents and circulating them within the bladder, significantly reducing the recurrence rate of cancer to less than 20%, compared to the traditional treatment, which has a recurrence rate of 78% and often necessitates multiple surgeries. By improving treatment outcomes and minimizing the need for further surgical interventions, Combat Medical's solution not only offers clinical benefits but also presents substantial cost savings. The company is planning to expand its operations into the UK market.

Message Missile, founded in 2013 by Thomas Young, specializes in location-based marketing solutions designed to enhance customer relationships and foster brand loyalty. The company develops mobile phone software that utilizes global positioning system (GPS) technology and geofences to deliver timely push notifications to users based on their current location. By partnering with some of the largest brands, Message Missile aims to improve engagement and create personalized marketing experiences that resonate with consumers in real-time.

Metal Powders & Process is seeking to build an atomiser that will produce metal powders is high volumes, with no impurities. The hope is that this will allow more industries to begin using metal powders to craft their components. Currently, contaminants in metal powders cause weak points in components, which are negligible for most purposes, but unusable under high stress in environments such as Aerospace.

Lightpoint Medical, Ltd., a medical device company, develops imaging technologies for cancer surgery. It develops Cerenkov Luminescence Imaging technology that detects cancer in real-time during surgery, and reduces the likelihood of cancer recurrence and the need for reoperation. Lightpoint Medical, Ltd. was formerly known as Artemis Diagnostics Ltd. and changed its name to Lightpoint Medical, Ltd. in January 2013. The company was founded in 2012 and is based in Rickmansworth, United Kingdom.

MicroVisk Limited, founded in 2004 and based in Oxford, United Kingdom, specializes in medical technology. The company has developed CoagMax, a point-of-care monitor that enables home testing for prothrombin time (PT) and international normalized ratio (INR) blood tests. In addition, MicroVisk is engaged in the creation of Micro Electro Mechanical Sensors, targeting the international medical market. By focusing on innovative solutions for blood testing and medical device technologies, MicroVisk aims to enhance patient care and facilitate easier access to vital health information.

IBEXIS TECHNOLOGIES is a leading provider of innovative sensory networking, remote data acquisition, monitoring and control products, systems and solutions. We have clients in a variety of industries including the Environmental, Building and Construction, Energy and Industrial sectors and they utilise our expertise to: Increase Customer Satisfaction Levels Significantly Reduce Operational Costs Improve Health and Safety in the Work Place Lower their Organisation’s Carbon Footprint Execute their CSR Strategies Ensure Regulatory Compliance Capable of supporting a variety of lead industry specific protocols, our solutions are used to remotely monitor and control industrial equipment (e.g. HMI’s and PLCs), sensors, probes as well as management and supervisory systems. Having an open systems approach enables our solutions to not only readily integrate into existing customer environments, but also extends (and often enhances) the capability of on-site systems to remote users who can securely access, control and monitor such systems using their laptop or smart device and also receive any relevant warnings and alerts. Our product and services portfolio is comprised of our IM SERIES Hardware and Systems product range, Enterprise Monitoring Software Suite, Managed Services, System Integration Services and Hardware and Software Product Development expertise.

Message Missile, founded in 2013 by Thomas Young, specializes in location-based marketing solutions designed to enhance customer relationships and foster brand loyalty. The company develops mobile phone software that utilizes global positioning system (GPS) technology and geofences to deliver timely push notifications to users based on their current location. By partnering with some of the largest brands, Message Missile aims to improve engagement and create personalized marketing experiences that resonate with consumers in real-time.

Combat Medical SL, based in Ajalvir, Spain, specializes in a novel treatment for superficial bladder cancer that enhances the efficacy of standard chemotherapy through a chemo-hyperthermia delivery system. This innovative approach involves heating chemotherapy agents and circulating them within the bladder, significantly reducing the recurrence rate of cancer to less than 20%, compared to the traditional treatment, which has a recurrence rate of 78% and often necessitates multiple surgeries. By improving treatment outcomes and minimizing the need for further surgical interventions, Combat Medical's solution not only offers clinical benefits but also presents substantial cost savings. The company is planning to expand its operations into the UK market.

BioMoti Limited develops cancer therapeutics. It seeks to transform the treatment of cancer by targeted delivery of therapeutics to the intracellular space of cancer cells. The company’s Oncojans are a new class of therapeutic microparticles that can target and gain entry to the interior of cancer cells where they slowly release drugs at the point of need whilst sparing healthy tissue. Its products also include MOTI1001, an Oncojans based ovarian cancer candidate. The company was incorporated in 2009 and is based in London, United Kingdom.

Run3D Limited operates clinics that specialize in musculoskeletal assessments to help individuals address persistent injuries. Founded in 2012 and based in Witney, United Kingdom, the company utilizes advanced three-dimensional gait analysis technology to evaluate biomechanics related to running injuries, performance issues, and footwear selection. Services are offered at various locations in the United Kingdom and Dublin, Ireland. Run3D employs a state-of-the-art motion capture system and draws on the world's largest biomechanical database to provide precise evaluations. The company aims to identify the root causes of injuries and develop personalized rehabilitation programs based on scientific measurements of gait, muscular strength, flexibility, and alignment. Collaborating with leading institutions such as the Running Injury Clinic at the University of Calgary, Run3D emphasizes an evidence-based approach to treating musculoskeletal overuse injuries.

Acunu Analytics offers a platform for low-latency, continuous analytics on big data; powering dashboards and embedded applications to monitor and control environments in manufacturing, telecommunications, media, financial services and other industries where high-velocity data must be analysed in real time. The Cassandra NoSQL database is at the core of the Acunu offering and Acunu is a very engaged Cassandra contributor donating many of its innovations back to the community. Acunu was founded in 2009 and is backed by some of Europe’s top VC funds. Started by a unique mix of researchers and engineers from Cambridge and Oxford Universities, Acunu has offices in London (near Old Street, London’s “Silicon Roundabout”) and California.

Azellon Limited is a company based in London, United Kingdom, that specializes in the development and commercialization of a unique tissue repair technology utilizing mesenchymal stem cells combined with a biological scaffold. The company's primary product, Cell Bandage, is designed for the repair of avascular meniscal tears in the knee, addressing a significant issue in orthopedic treatment where surgeons often resort to partial or complete meniscus removal. This conventional approach can lead to osteoarthritic changes in the knee joint over time. Developed by Professor Anthony Hollander, Azellon's technology has demonstrated notable success in in-vitro models over a five-year research period. Established in 2007, Azellon Limited aims to offer a more effective solution for knee injuries that preserves the meniscus and promotes natural healing.

Select Technology is a design and engineering company, provides software solutions for the copier and multi-function device industry. It offers PaperCut MF, a print, copy, fax, and scan management solution; KPAX Manage, a print fleet management solution for resellers; Presto, which enables users to publish existing Windows print queues to iOS device; EveryonePrint, a mobile print solution; Drivve Image, a scanning software; and selectSCAN, a scanning and capture solution for employees.

Orthogem Limited specializes in developing and manufacturing synthetic bone grafts, utilizing its patented Tripore technology platform. This innovative platform has led to a diverse range of synthetic bone grafts (SBGs) designed for various clinical applications, including spinal and oral craniofacial surgeries. Orthogem's product offerings include TriPore Granules, TriPore MPA, and TriPore Blocks. Established in 2001 and headquartered in Nottingham, United Kingdom, the company focuses on achieving optimal bone remodeling through the osteoconductive and bioactive properties of its materials. These grafts are applicable for treating a wide array of conditions, including fractures, congenital disorders, traumatic injuries, and bone cancer, thereby providing reliable solutions for patients undergoing procedures such as lumbar spine fusion.

MicroVisk Limited, founded in 2004 and based in Oxford, United Kingdom, specializes in medical technology. The company has developed CoagMax, a point-of-care monitor that enables home testing for prothrombin time (PT) and international normalized ratio (INR) blood tests. In addition, MicroVisk is engaged in the creation of Micro Electro Mechanical Sensors, targeting the international medical market. By focusing on innovative solutions for blood testing and medical device technologies, MicroVisk aims to enhance patient care and facilitate easier access to vital health information.

Crysalin Limited, founded in June 2007 and based in London, specializes in the research and development of crysalin lattice technology, which is derived from patented work initiated in 2002 at the Oxford University Laboratory of Molecular Biophysics. The company's core product, crysalins, is a protein-based nanotechnology that significantly enhances the determination of protein structures, particularly for challenging targets such as membrane proteins and soluble proteins with flexible regions. Crysalins enable the resolution of three-dimensional molecular structures using X-ray and electron microscopy techniques, where traditional methods have struggled. In addition to protein structure determination, crysalins hold potential applications in biosensor development and optoelectronics, showcasing the versatility and innovative capacity of the technology.

Acunu Analytics offers a platform for low-latency, continuous analytics on big data; powering dashboards and embedded applications to monitor and control environments in manufacturing, telecommunications, media, financial services and other industries where high-velocity data must be analysed in real time. The Cassandra NoSQL database is at the core of the Acunu offering and Acunu is a very engaged Cassandra contributor donating many of its innovations back to the community. Acunu was founded in 2009 and is backed by some of Europe’s top VC funds. Started by a unique mix of researchers and engineers from Cambridge and Oxford Universities, Acunu has offices in London (near Old Street, London’s “Silicon Roundabout”) and California.

MicroVisk Limited, founded in 2004 and based in Oxford, United Kingdom, specializes in medical technology. The company has developed CoagMax, a point-of-care monitor that enables home testing for prothrombin time (PT) and international normalized ratio (INR) blood tests. In addition, MicroVisk is engaged in the creation of Micro Electro Mechanical Sensors, targeting the international medical market. By focusing on innovative solutions for blood testing and medical device technologies, MicroVisk aims to enhance patient care and facilitate easier access to vital health information.

LabMinds Limited specializes in automating solution preparation for liquid-handling laboratories across the globe, particularly in the pharmaceutical and life sciences sectors. Founded in 2009 and headquartered in Oxford, United Kingdom, with an additional office in Somerville, Massachusetts, the company offers The Revo solution preparation system. This innovative platform combines artificial intelligence and robotics to streamline the drug development process, addressing the challenges of manual operations that often lead to errors and waste. By connecting its system to a cloud-based platform, LabMinds enables remote access and facilitates the collection of input and sensor data, providing valuable insights into chemical interactions. The company aims to enhance laboratory accuracy and control while accelerating the development of meaningful therapies, thereby supporting scientists and businesses in optimizing their operations.

Glide Pharmaceutical Technologies Limited is a clinical-stage development company based in Abingdon, United Kingdom, specializing in solid dose formulations of therapeutics and vaccines. The company has developed the Solid Dose Injector (SDI) system, aimed at enhancing patient compliance for those self-administering long-term therapies. Its product pipeline includes solid dose formulations for medications such as octreotide, teriparatide, and vaccines for anthrax and influenza. Additionally, Glide is working on a novel non-invasive diagnostic technology focusing on prostate cancer, which seeks to identify clinically significant disease through a biochemical marker. Founded in 2001, the company was previously known as Caretek Medical Ltd. before rebranding in 2006.

Base4 Innovation Ltd. is a company based in Cambridge, United Kingdom, that specializes in the development of advanced detection platforms for the healthcare and life sciences sectors. Founded in 2007, Base4 focuses on cutting-edge technologies for single-molecule analysis, particularly through its microdroplet-based sequencing technology. This innovative approach allows for pathogen screening and DNA analysis by generating long reads from individual DNA molecules without the need for initial amplification. The technology aims to enhance the understanding and prediction of diseases while providing more accurate and cost-effective sequencing data for large populations. In addition to its technical advancements, Base4 is committed to building a valuable portfolio of intellectual property and expertise.

MicroVisk Limited, founded in 2004 and based in Oxford, United Kingdom, specializes in medical technology. The company has developed CoagMax, a point-of-care monitor that enables home testing for prothrombin time (PT) and international normalized ratio (INR) blood tests. In addition, MicroVisk is engaged in the creation of Micro Electro Mechanical Sensors, targeting the international medical market. By focusing on innovative solutions for blood testing and medical device technologies, MicroVisk aims to enhance patient care and facilitate easier access to vital health information.

Diamond Microwave Devices Ltd. engages in the development of semiconductor devices based on CVD diamond. Its devices are used in civil and defense systems for microwave power amplifier and transmitter applications. The company was founded in 2006 and is based in Leeds, the United Kingdom. Diamond Microwave Devices Ltd. operates as a subsidiary of Element Six (Pty) Ltd.

Acunu Analytics offers a platform for low-latency, continuous analytics on big data; powering dashboards and embedded applications to monitor and control environments in manufacturing, telecommunications, media, financial services and other industries where high-velocity data must be analysed in real time. The Cassandra NoSQL database is at the core of the Acunu offering and Acunu is a very engaged Cassandra contributor donating many of its innovations back to the community. Acunu was founded in 2009 and is backed by some of Europe’s top VC funds. Started by a unique mix of researchers and engineers from Cambridge and Oxford Universities, Acunu has offices in London (near Old Street, London’s “Silicon Roundabout”) and California.

Azellon Limited is a company based in London, United Kingdom, that specializes in the development and commercialization of a unique tissue repair technology utilizing mesenchymal stem cells combined with a biological scaffold. The company's primary product, Cell Bandage, is designed for the repair of avascular meniscal tears in the knee, addressing a significant issue in orthopedic treatment where surgeons often resort to partial or complete meniscus removal. This conventional approach can lead to osteoarthritic changes in the knee joint over time. Developed by Professor Anthony Hollander, Azellon's technology has demonstrated notable success in in-vitro models over a five-year research period. Established in 2007, Azellon Limited aims to offer a more effective solution for knee injuries that preserves the meniscus and promotes natural healing.

Warwick Effect Polymers Limited manufactures and markets complex polymers using living controlled radical polymerization.

OrganOx Limited, founded in 2008 and based in Oxford, United Kingdom, specializes in organ preservation and transplantation technology, particularly for liver transplants. The company has developed the Metra device, which employs normothermic preservation technology to store livers outside the body at normal body temperature. This innovative approach mimics the conditions of the human body by continuously perfusing the liver with oxygen-carrying red cells and nutrients, thereby preventing the decay of the organ before transplantation. The Metra device enables the liver to produce bile, metabolize glucose, and maintain a physiological pH level, ultimately enhancing the viability of the organ for transplant. OrganOx's research and development efforts are rooted in the work of Prof Peter Friend and Prof Constantin Coussios at the University of Oxford.

Mirriad’s award-winning solution unleashes new revenue for content producers and distributors by creating new advertising inventory in content. Our patented, AI and computer vision technology dynamically inserts products and innovative signage formats after content is produced. Mirriad’s market-first solution seamlessly integrates with existing subscription and advertising models, and dramatically improves the viewer experience by limiting commercial interruptions. Mirriad currently operates in the US, Europe and China.

Agilent Raman Spectroscopy’s proprietary technologies use novel variants of Raman spectroscopy. Their instruments can rapidly and accurately identify materials hidden inside objects or through opaque barriers such as plastic, coloured glass, paper and skin, or can measure the concentrations of materials in mixtures, with a high degree of accuracy. Agilent Raman Spectroscopy is formerly known as Cobalt Light Systems and is part of Agilent.

Meciria develops an oil well drilling tool for the oil industry.

Glide Pharmaceutical Technologies Limited is a clinical-stage development company based in Abingdon, United Kingdom, specializing in solid dose formulations of therapeutics and vaccines. The company has developed the Solid Dose Injector (SDI) system, aimed at enhancing patient compliance for those self-administering long-term therapies. Its product pipeline includes solid dose formulations for medications such as octreotide, teriparatide, and vaccines for anthrax and influenza. Additionally, Glide is working on a novel non-invasive diagnostic technology focusing on prostate cancer, which seeks to identify clinically significant disease through a biochemical marker. Founded in 2001, the company was previously known as Caretek Medical Ltd. before rebranding in 2006.

Novacta Biosystems Ltd, founded in 2003, specializes in the development of biopharmaceuticals aimed at treating bacterial infections, particularly those caused by drug-resistant strains. The company employs a dual business model that combines biocatalysis and microbial pathway engineering services with the discovery and development of novel small peptide molecules known as lantibiotics. These innovative therapies target various bacterial infections, including Clostridium difficile. By leveraging the expertise of GSK's Biotransformation and Natural Products scientific team, Novacta has established a robust infectious disease therapeutic pipeline, focusing on delivering effective anti-infective solutions.

Arecor Limited is a biopharmaceutical company based in Cambridge, United Kingdom, specializing in the development of innovative stabilization technology solutions for pharmaceutical and biotech firms. The company partners with these organizations to enhance the commercial value and utility of proteins used in various applications, including vaccines, therapeutic proteins, and treatments for complex diseases. Arecor focuses on developing products for areas such as diabetes, oncology, immunology, and infectious diseases, working to reformulate existing therapies to improve their efficacy and ease of use. Its innovative formulation technology enables high concentrations of antibodies for at-home self-administration and stable liquid formulations for biological therapies. Arecor also addresses challenges related to protein degradation and stability, particularly in the formulation of growth hormones and vaccines. Founded in 2006, Arecor operates primarily in the UK and has a global reach, collaborating with leading pharmaceutical and biotech companies to deliver enhanced therapeutic solutions.

Historic Futures Ltd specializes in supply-chain traceability solutions, providing advanced technologies and consulting expertise to help brands and retailers visualize and manage their supply chains. Founded in 2003 and based in Witney, United Kingdom, the company offers the String3 platform, which allows organizations to share comprehensive product and process information, identify risk areas, and communicate best practices. Their software facilitates the collection of reliable, up-to-date data, enabling clients to understand the history of their products, reduce risks, and create sustainable value. By connecting organizations with their supply chains, Historic Futures enhances the ability to send and receive traceability information, detailed risk reports, and file attachments through a unified platform.

Pharma Engineering has developed and patented a gentle method to remove tablets and capsules from blister packs without damaging them. The pharmaceutical industry is large and manufactures billions of blister-packaged tablets. It is common for 2-6% of this manufactured product to be stopped for quality reasons relating to the packaging. Recovering these tablets so that they can be re-packaged can yield easy savings.

Oxtox is developing Drugsensorâ„¢, a device that uses novel and cost-effective technology to rapidly detect whether a person is currently 'under the influence' of specific drugs, all with a minimum of inconvenience.

Incentec Ltd has been developing a predictive diagnostic for pre-eclampsia, a poorly defined condition affecting approximately 6% of first pregnancies. The causes of pre-eclampsia are unknown, although a failure in placental development is thought to be a factor. There is no diagnostic test currently in use and at the moment, at-risk patients (or suspected cases of pre-eclampsia) are monitored and treated on the basis of observable and developing clinical symptoms.

Imagineer Systems Limited offers research, development, and marketing services for visual effects solutions in film, video, and broadcast post production. Its products include monet, a tracking and compositing toolset and mokey, a toolset for removing wires, rigs, logos, scratches, and hairs for commercial, film, and corporate video post production. Additionally, the company provides mocha, a 2D tracking and rotoscoping tool that generates position, scale, rotation, shear, and perspective matched tracks for special effects in film and video production. Imagineer Systems also offers virtual product placement, lens distortion correction, noise reduction, grain management, and keying tools. Imagineer Systems Limited was founded in 2000 and is based in Guildford, United Kingdom.

Dexela develops a 3-D breast imaging technology for the early detection of breast cancer. It offers DexTop Digital Mammography Workstation, a screening workstation that ensures screening workflow and performance; and Dexela 3D reconstruction engine that is offered to OEM partners as a software module with licensing terms. The company provides flat panel CMOS X-ray detectors that are used in various medical applications, including mammography and tomosynthesis, breast CT, dental CBCT, fluoroscopy, cardiology and angiographic imaging, and bone densitometry, as well as in scientific instrumentation and non-destructive testing applications. It also offers consulting services in the areas of digital tomosynthesis, mammography acquisition geometry, and optimal reconstruction of 3D data; and design and implementation resources for hardware and software engineering projects. Dexela Limited was incorporated in 2003 and is based in London, the United Kingdom. It has an X-ray research and development facility in Sudbury, Massachusetts.

Usentric develops online proxy solution for brands in the retail, financial services and telecommunication industries. The company's products and services include secure payment online solutions, email protection, and secure ID. It is based in Sutton, U.K.

Naked Objects Group provides Java-based application development platforms.

Glide Pharmaceutical Technologies Limited is a clinical-stage development company based in Abingdon, United Kingdom, specializing in solid dose formulations of therapeutics and vaccines. The company has developed the Solid Dose Injector (SDI) system, aimed at enhancing patient compliance for those self-administering long-term therapies. Its product pipeline includes solid dose formulations for medications such as octreotide, teriparatide, and vaccines for anthrax and influenza. Additionally, Glide is working on a novel non-invasive diagnostic technology focusing on prostate cancer, which seeks to identify clinically significant disease through a biochemical marker. Founded in 2001, the company was previously known as Caretek Medical Ltd. before rebranding in 2006.

Inspiration Matters has developed a software and hardware system to drive high quality displays such as those used in car dealerships, estate agents and banks.

Impact Applications Ltd. specializes in designing, developing, and supporting enterprise software applications tailored for various industries. The company offers a range of products, including impactRESPONSE, which serves the repairs and maintenance needs of social housing and insurance reinstatement; impactUNWIRED, a wireless barcode scanning application for component distribution; impactCONNECT, a platform for bulk SMS and voice messaging; and impactCOMMERCE, an integrated e-commerce solution. In addition to its software offerings, the company provides consultancy and support services, such as maintenance contracts and helpdesk assistance. Founded in 2000, Impact Applications Ltd. is headquartered in Wolverhampton, United Kingdom, and operates as a subsidiary of Castleton Technology plc.

Dynamic Extractions Ltd. is a chromatography company based in Slough, United Kingdom, established in 2001. The firm specializes in the development of advanced separation technologies, particularly its proprietary Hydrodynamic Counter Current Chromatography (HdCCC) technology. Dynamic Extractions manufactures a range of high-performance chromatographic instruments, including those for kilogram or industrial scale, preparative, analytical, and semi-preparative chromatography. These technologies support drug research, development, and production by enabling the purification and isolation of various compounds, from small molecules to macromolecules, for quantities ranging from milligrams to kilos. Additionally, the company's innovations cater to applications in medicinal chemistry, continuous processing, and chiral separation, thereby enhancing efficiency for its clients in the laboratory and industrial sectors.

Wright Fenn provides medicine pills are manufactured and packaged in blister packs. For many patients, such as those in residential or care homes, hospitals or other institutions, these pills are repackaged by the pharmacy into dosage specific monthly packs to save nursing time and reduce dosage errors. Pharmaceutical licenses typically specify the form of the packaging and so it is expensive for the manufacturers to make and package pills in bulk form for pharmacies to repackage them into dosage specific packs. During 2003, pharmacists in the UK alone deblistered and repackaged approximately 70 million packs of pills ' mostly by hand. The number of patients requiring these patient specific packs is increasing each year at about 10-15%.

Kinomi provides a better way of automatically archiving and indexing email, both by subject matter, sender and receiver groups, and by reading content, which then enables people and organisations to retrieve relevant emails much more easily, if ever they are needed at some point in the future.

BioAnaLab Ltd. is a services provider that specializes in the analysis of biologic drugs and vaccines. BioAnaLab was spun out of the University of Oxford in 2002 to meet the unique requirements of the biopharmaceutical industry. The Company helps its customers better understand the safety and efficacy of biologic drugs and vaccines by providing a broad range of services to assist with evaluating and advancing these therapeutics from the drug development pipeline to the market

Water Innovate focuses on bridging the gap between research and industry innovation in the water and environmental sectors. The company specializes in the development and commercialization of advanced water and wastewater treatment technologies. By evaluating new technologies and investing resources in their development, Water Innovate effectively identifies routes to market. Their portfolio includes a variety of cutting-edge products designed by leading experts in the field, aimed at addressing the challenges faced by the water industry. These technologies are systematically transferred from research laboratories to the marketplace, facilitating practical solutions for the international water and environmental sectors.

Scancell Holdings plc is focused on the discovery and development of innovative vaccines aimed at treating various cancers and infectious diseases. The company's primary product candidates include SCIB1, currently in phase II clinical trials for metastatic melanoma, and SCIB2, which is undergoing phase I/II combination trials for non-small cell lung cancer. Additionally, Modi-1 is in phase I/II clinical trials targeting head and neck, triple negative breast, ovarian, and renal cancers, while Modi-2 is in pre-clinical trials for multiple solid tumors. Scancell utilizes its ImmunoBody® and Moditope™ technology platforms to develop these therapeutic vaccines. The company has established collaborations with BioNTech for T-cell receptor based therapeutics, ISA Pharmaceuticals B.V. for utilizing AMPLIVANT adjuvant technology, and several academic institutions for COVID-19 vaccine development. Founded in 1997 and based in Oxford, United Kingdom, Scancell is dedicated to advancing cancer immunotherapy.

Inscentinel uses the exquisitely sensitive olfactory sense of bees to detect minute concentrations of volatile compounds such as explosives, drugs, or odours that indicate disease. The bees are held in a harness and can then be trained to recognize particular scents, in much the same way that sniffer dogs can be trained. In the presence of the odour for which they have been trained, the bees have a proboscis extension reflex, and this is then picked up by a camera and its associated software that then sends a signal to an operator or simply logs the data. A US patent has been granted and other patent applications are proceeding.

Caretek Medical has developed a needle-free injection technology. The system comprises a hand-held spring-powered reusable actuator plus a single-use disposable cassette which houses a splinter of drug in solid form. In use, the cassette is engaged with the actuator and then pressed against the skin. This pressure further charges an internal spring and, at the critical point, the internal components are brought into alignment, releasing the spring which then causes the drug splinter to be pushed to a controlled and repeatable depth within the skin. The basic idea is covered by a number of patent applications which have recently started to grant.

Warwick Effect Polymers Limited manufactures and markets complex polymers using living controlled radical polymerization.

Diamond Hard Surfaces Ltd. is a materials technology company based in Towcester, United Kingdom, established in 2004. The company specializes in producing Adamant, an amorphous diamond-like carbon coating that enhances the performance of various substrates, including steel and thermoplastics. These coatings are designed to improve durability by reducing friction, enhancing wear resistance, and providing superior load-carrying capabilities. Diamond Hard Surfaces employs a patented process that allows for the application of thicker layers at lower temperatures, making the coatings suitable for demanding environments such as aerospace, defense, oil and gas, medical, motorsport, and process plants. The unique characteristics of the Adamant coatings, including their low coefficient of friction and excellent resistance to chemical corrosion, make them ideal for extending the life and performance of components in challenging conditions.

Novacta Biosystems Ltd, founded in 2003, specializes in the development of biopharmaceuticals aimed at treating bacterial infections, particularly those caused by drug-resistant strains. The company employs a dual business model that combines biocatalysis and microbial pathway engineering services with the discovery and development of novel small peptide molecules known as lantibiotics. These innovative therapies target various bacterial infections, including Clostridium difficile. By leveraging the expertise of GSK's Biotransformation and Natural Products scientific team, Novacta has established a robust infectious disease therapeutic pipeline, focusing on delivering effective anti-infective solutions.

Scancell Holdings plc is focused on the discovery and development of innovative vaccines aimed at treating various cancers and infectious diseases. The company's primary product candidates include SCIB1, currently in phase II clinical trials for metastatic melanoma, and SCIB2, which is undergoing phase I/II combination trials for non-small cell lung cancer. Additionally, Modi-1 is in phase I/II clinical trials targeting head and neck, triple negative breast, ovarian, and renal cancers, while Modi-2 is in pre-clinical trials for multiple solid tumors. Scancell utilizes its ImmunoBody® and Moditope™ technology platforms to develop these therapeutic vaccines. The company has established collaborations with BioNTech for T-cell receptor based therapeutics, ISA Pharmaceuticals B.V. for utilizing AMPLIVANT adjuvant technology, and several academic institutions for COVID-19 vaccine development. Founded in 1997 and based in Oxford, United Kingdom, Scancell is dedicated to advancing cancer immunotherapy.

Hardide Coatings is a UK-based manufacturer of tungsten carbide-based coatings designed for both external and internal surfaces of metal components. Established in 2000 and headquartered in Bicester, the company specializes in low-temperature chemical vapor deposition coatings that enhance the durability of critical metal parts exposed to abrasive, erosive, corrosive, and chemically aggressive environments. Hardide's products are utilized across various high-value industries, including oil and gas, aerospace, petrochemical, power generation, and industrial tooling. The company's coatings are tailored for diverse applications, improving wear and corrosion resistance while combining toughness with ductility, ultimately extending the lifespan of essential components. Hardide operates in multiple regions, including the UK, Europe, and North America.

Invro Limited operates as an electronic engineering company. The company focuses on the management of electrical energy by electronic means. It offers single earpiece radios, radio receiver sets, and FM radios. The company also provides high voltage power supplies for scientific and industrial applications; and instrumentation for power electronics applications. Invro Limited was incorporated in 2003 and is based in Bristol, the United Kingdom.

Caretek Medical has developed a needle-free injection technology. The system comprises a hand-held spring-powered reusable actuator plus a single-use disposable cassette which houses a splinter of drug in solid form. In use, the cassette is engaged with the actuator and then pressed against the skin. This pressure further charges an internal spring and, at the critical point, the internal components are brought into alignment, releasing the spring which then causes the drug splinter to be pushed to a controlled and repeatable depth within the skin. The basic idea is covered by a number of patent applications which have recently started to grant.

Ciphergrid Ltd (previously Cipherware Ltd) has developed what it believes is a unique data access technology that, in its simplest form, enables enterprise applications (e.g. ERP, CRM, or stand alone applications such as MS Excel) to perform transactions with multiple, disparate, remote databases across the Internet in the same way (speed, functionality, security) as if the databases were local. Ciphergrid's uniqueness lies in the fact that it offers a reliably high transactional speed, that it is a 'plug & play' solution and that it offers significantly lower total cost of ownership than any alternative. Its built-in data encryption and security control mechanisms allow the use of the Internet instead of expensive, non scaleable, leased lines.

Telegesis Ltd. specializes in the design, manufacture, and supply of ZigBee modules based on Silicon Labs' technology, catering to various markets including consumer, commercial, industrial, and government sectors worldwide. The company provides a diverse range of products, such as ZigBee radio modules, thread modules, development kits, USB sticks, and smart energy compliant devices, along with external antennas and off-the-shelf firmware. Telegesis's offerings support applications in smart energy, building lighting and control, renewable energy, and home automation, enabling devices to communicate over distances of up to one kilometer through self-configuring mesh networks. Telegesis distributes its products through distributors and sales representatives in the United States, as well as online, and maintains strategic partnerships with several technology companies. Established in 1998, Telegesis is headquartered in High Wycombe, United Kingdom, and operates as a subsidiary of Silicon Laboratories Inc.

ReviveR Technologies Limited, (formerly known as PC Help Centre) is a UK based research and development company, which specialises in designing intelligent remote diagnostic tools for use within mission-critical PCs, servers and manufacturing control equipment. Today, ReviveR Technologies offer affordable diagnostic tools that provide advanced, yet simplified secure remote access, monitor and control management for mission-critical equipment 24/7/365. The essence of the technology is that a board or chip resides in a PC or server and reports back over the internet on the detailed status of the PC. If a fault develops, the fault is reported. If it cant be corrected remotely as is often possible with software faults, then an engineer is able to arrive with the necessary hardware module so that the fault may be fixed at a single visit.

Commerce Decisions delivers proven software – AWARD, best practice knowledge and expert services to assist sourcing projects through-life; from preparation, qualification, evaluation, negotiation to continuous supplier performance review and contract compliance. AWARD software provides a central web-based information and process & infrastructure enabling project teams to collaboratively make major contract decisions and monitor subsequent performance. It is proven to significantly increase contract value and reduce risk and used in projects totalling over £150 billion to date. AWARD is available in the UK via a number of routes, including CCS frameworks. Commerce Decisions customers include the Department for Transport, DWP, Defra, Transport for London, NHS, the UK Olympic Delivery Authority, the British Broadcasting Corporation, defence contractors and the UK and Finnish MOD.

The Im-Pak technology has now been successfully demonstrated on three moulds, a water cup, a paint-can, and on a mould for a pre-form for PET bottles. In January 2006, Im-Pak agreed heads of terms by which a public company will take a licence for the Im-Pak process for use in certain market areas. At the time of writing, the deal has reached draft legal contract stage, and it is expected that the deal will be concluded in May. Im-Pak will receive both regular monthly payments, as advance royalties, plus two lump-sum payments, and will share in royalties generated by licensing the technology round the world. Im-Pak will continue to develop the technology for other applications.

Inscentinel uses the exquisitely sensitive olfactory sense of bees to detect minute concentrations of volatile compounds such as explosives, drugs, or odours that indicate disease. The bees are held in a harness and can then be trained to recognize particular scents, in much the same way that sniffer dogs can be trained. In the presence of the odour for which they have been trained, the bees have a proboscis extension reflex, and this is then picked up by a camera and its associated software that then sends a signal to an operator or simply logs the data. A US patent has been granted and other patent applications are proceeding.

Concurrent Thinking Limited specializes in the design and implementation of large-scale computing infrastructures and software tailored for high-performance computing. Based in Warwick, United Kingdom, the company offers a range of data center infrastructure management solutions, including concurrentCOMMAND, which integrates with facilities management systems to optimize energy efficiency, and concurrentCONTROL, a platform for monitoring power, environmental conditions, servers, and operating systems within data centers. Additionally, Concurrent Thinking provides support and maintenance services to its clients, which include IT, environmental, and financial sectors, as well as facilities management. Established in 2009 and formerly known as Retromaze Limited, the company rebranded in June 2010 to reflect its focus on innovative approaches to system management and scalable computing solutions.

Inaplex is a developer of a technology platform focused on customer data integration, offering a suite of customer relationship management (CRM) and enterprise integration software. This platform provides businesses with code-free tools for transferring client information between CRM systems and other data sources. By facilitating the collection, migration, and integration of data across various enterprise platforms, Inaplex enables organizations to access clean and accurate information. This capability supports smooth operational processes and empowers informed decision-making, ultimately enhancing business efficiency and effectiveness.

Metal Nanopowders Ltd. is a manufacturer and supplier of high-quality metal powders, specializing in nanopowders such as aluminum, iron, copper, nickel, magnesium, titanium, and titanium nitride. Established in 2002, the company is based in Birmingham, United Kingdom, and originated as a spinout from the University of Birmingham. Metal Nanopowders Ltd. focuses on the production and development of nanopowders in varying quantities, utilizing a patented process that ensures exceptional purity and physical properties. The company's commitment to innovation and quality positions it as a key player in the field of advanced materials.